prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review
To illustrate how we used these genotype-specific risks for clinical research, I will talk about the GIFT-D project, which was funded by the Department of Defense.  Predictive genetic testing for T1D is being performed for several natural history studies.  Therefore, we developed a theory-based web education and risk communication program for families with T1D.  Our concern was with the ethics of performing HLA testing on healthy children who have a sibling with T1D, given that the disease cannot be prevented.  Therefore, we wanted to make sure that families were well informed of the risks and benefits of predictive genetic testing for T1D.